Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent to Present at 41st Annual J.P. Morgan Healthcare Conference 2023-01-05 00:00
Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program 2023-01-04 21:00
OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors 2023-01-04 21:00
Transcenta Received IND Clearance from NMPA for Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors 2023-01-04 08:00
Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum 2023-01-03 23:25
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test 2023-01-03 22:24
Bridge Biotherapeutics to Present at BIOTECH SHOWCASE™ 2023 2023-01-03 22:00
Call for Application for 2023 Tsinghua Amgen Scholars Program 2023-01-03 21:20
Steakholder Foods® Receives Grant of up to $1M for Collaboration with Umami Meats to 3D Bio-Print Structured Cultivated Fish Products 2023-01-03 20:00
ProfoundBio Announces Initiation of First-in-Human Trial for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Receives FDA "Study May Proceed" Letter for PRO1160, a CD70-Directed ADC 2023-01-03 20:00
Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company 2023-01-03 16:00
Antengene to Present at the 41st Annual J.P. Morgan Healthcare Conference 2023-01-03 14:10
Bayer Taiwan Company Ltd. and Berocca Honored at the Asia Pacific Enterprise Awards 2022 Taiwan 2023-01-03 10:05
CStone announces the registrational clinical trial of sugemalimab as first-line treatment in patients with esophageal squamous cell carcinoma met primary endpoints and plans to submit a supplemental NDA to NMPA 2023-01-03 08:10
Ascletis Believes that the Complaints Made by Viking Therapeutics Have No Merit and will Vigorously Defend Against such Complaints 2023-01-02 19:24
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates 2022-12-30 21:00
Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19 2022-12-30 13:23
Everest Medicines to Hold New Corporate Strategy Online Conference Calls 2022-12-30 08:05
Everest Medicines Announces China NMPA Recommends Priority Review for Nefecon for the Treatment of Primary IgA Nephropathy 2022-12-30 08:00
Complete Genomics to Present its Multiple, Innovative Sequencing Platforms at BIOTECH SHOWCASE™ 2023 2022-12-30 01:58
1 93 94 95 96 97 412